Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.

导出 LinkOut

翻译打印收藏纠错

作者： Angelos K,Koutras ^[1] ; George,Fountzilas ; Urania,Dafni ; Meletios A,Dimopoulos ; Dimitrios,Pectasides ; George,Klouvas ; Pavlos,Papakostas ; Paris,Kosmidis ; Epaminondas,Samantas ; Helen,Gogas ; Evangelos,Briasoulis ; Georgia,Vourli ; Theodoros,Petsas ; Nikolaos,Xiros ; Haralabos P,Kalofonos ; Hellenic Cooperative Oncology Group

作者单位： Division of Oncology, Department of Medicine, University Hospital of Patras, Patras Medical School, Rio, Greece. angkoutr@otenet.gr ^[1]

主题词成年人(Adult);老年人(Aged);贫血(Anemia);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);卡铂(Carboplatin);表柔比星(Epirubicin);女(雌)性(Female);血液病(Hematologic Diseases);人类(Humans);中年人(Middle Aged);中性粒细胞减少(Neutropenia);紫杉酚(Paclitaxel);预后(Prognosis);回顾性研究(Retrospective Studies);血小板减少(Thrombocytopenia)

PMID 19031934

发布时间 2015-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Anticancer research

2913-20页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.

Anticancer research

相似文献

Anticancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.

Anticancer research

相似文献

Anticancer research

相关期刊

检索历史清除